Senior Machine Learning Engineer at Abata Therapeutics

South San Francisco, California, United States

Abata Therapeutics Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Drug DiscoveryIndustries

Requirements

  • Solid Engineering and Computer Science fundamentals, ideally with a degree in CS, Math, or equivalent experience
  • Exceptional engineering skills to iterate quickly on data processing and training pipelines
  • Experience in building, testing, training, and deploying modern neural network architectures such as Transformers
  • Experience with frameworks like PyTorch, Tensorflow, Keras, JAX and the ability to write hardware optimized code for distributed training
  • (Desirable) Experience with distributed deep learning using frameworks such as HF Accelerate, Deepspeed, Composer, TorchTitan, Megatron etc
  • (Desirable) Experience with training large neural networks on multiple compute nodes

Responsibilities

  • Stay at the forefront of ML and computational biology research and rapidly adopt state-of-the-art techniques to train AI virtual cell models on massive single cell datasets
  • Work together with ML Scientists to develop the next generation of compute optimized models like Tahoe-x1

Skills

Key technologies and capabilities for this role

Machine LearningDeep LearningFoundation ModelsSingle-Cell AnalysisGene Regulatory NetworksStatisticsPythonPyTorchScalable MLModel Architecture

Questions & Answers

Common questions about this position

What benefits are offered for this role?

The position offers unlimited Paid Time Off (PTO) and a monthly benefit.

Is this a remote position or does it require office work?

This information is not specified in the job description.

What salary or compensation can I expect?

This information is not specified in the job description.

What skills are required for the Senior Machine Learning Engineer role?

Required skills include solid engineering and computer science fundamentals (ideally with a degree in CS, Math, or equivalent), exceptional engineering skills for data processing and training pipelines, experience with modern neural network architectures like Transformers, and proficiency with frameworks like PyTorch, Tensorflow, Keras, JAX, including hardware-optimized code for distributed training.

What kind of company culture is there at Tahoe Therapeutics?

The company embodies a philosophy of 'build in the open, shoot for the moon,' seeks non-incremental thinkers to push the frontier of what's possible, and emphasizes working together with ML Scientists on cutting-edge projects.

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI